Equities

Tinavi Medical Technologies Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Tinavi Medical Technologies Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)25.06
  • Today's Change-0.09 / -0.36%
  • Shares traded8.13m
  • 1 Year change+111.48%
  • Beta1.7157
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Tinavi Medical Technologies Co Ltd had revenues fall -14.85% from 210.04m to 178.84m, though the company grew net income from a loss of 156.39m to a smaller loss of 121.13m.
Gross margin70.09%
Net profit margin-62.01%
Operating margin-45.73%
Return on assets-10.37%
Return on equity-13.10%
Return on investment-11.54%
More ▼

Cash flow in CNYView more

In 2024, cash reserves at Tinavi Medical Technologies Co Ltd fell by 24.06m. However, Cash Flow from Investing totalled 75.74m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 98.65m for operations while cash used for financing totalled 1.79m.
Cash flow per share--
Price/Cash flow per share--
Book value per share2.74
Tangible book value per share2.64
More ▼

Balance sheet in CNYView more

Tinavi Medical Technologies Co Ltd has a Debt to Total Capital ratio of 14.08%, a higher figure than the previous year's 11.95%.
Current ratio3.21
Quick ratio2.94
Total debt/total equity0.1695
Total debt/total capital0.1408
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.